These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 2798572)

  • 1. [Clinical study of a 6-month chemotherapy regimen in the treatment of pulmonary tuberculosis. Results approximately 2 years after completion of chemotherapy].
    Fortic B
    Plucne Bolesti; 1989; 41(1-2):46-57. PubMed ID: 2798572
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Characteristics and treatment outcomes of INH-resistant or RFP-resistant tuberculosis].
    Saito W; Nagayama N; Miyamoto M; Hara H; Suzuki J; Masuda K; Baba M; Tamura A; Nagai H; Akagawa S; Kawabe Y; Machida K; Kurashima A; Yotsumoto H
    Kekkaku; 2003 Oct; 78(10):611-7. PubMed ID: 14621568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fixed-dose combination chemotherapy (Rifater/Rifinah) for active pulmonary tuberculosis in Taiwan: a two-year follow-up.
    Su WJ; Perng RP
    Int J Tuberc Lung Dis; 2002 Nov; 6(11):1029-32. PubMed ID: 12475151
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long term follow up of HIV-infected patients with tuberculosis treated with 6-month intermittent short course chemotherapy.
    Swaminathan S; Deivanayagam CN; Rajasekaran S; Venkatesan P; Padmapriyadarsini C; Menon PA; Ponnuraja C; Dilip M
    Natl Med J India; 2008; 21(1):3-8. PubMed ID: 18472696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Tuberculosis treatment today].
    Nowak D; Radenbach D; Kirsten D; Magnussen H
    Z Gesamte Inn Med; 1991 Aug; 46(10-11):404-9. PubMed ID: 1926948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment outcomes of multidrug-resistant tuberculosis--comparison between success and failure cases].
    Shigetoh E; Murakami I; Yokosaki Y; Kurimoto N
    Kekkaku; 2001 Dec; 76(12):723-8. PubMed ID: 11806128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Immediate and late results of the use of "3 + 6" regimens in the routine treatment of pulmonary tuberculosis].
    Didilescu C; Panghea P; Pavlidi N; Purcăreanu G; Roman G
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1978; 27(1):37-40. PubMed ID: 206942
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Efficacy of the standard regimen for initial treatment of pulmonary tuberculosis: results of long-term followed-up].
    Wada M; Yoshiyama T; Sugie T; Nakazono T; Ogata H; Sugita H
    Kekkaku; 1994 Apr; 69(4):301-6. PubMed ID: 8189683
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Short-term chemotherapy of tuberculosis in children].
    Hussein A
    Pneumologie; 1990 Jan; 44(1):24-31. PubMed ID: 2408034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A controlled trial of 6 months' chemotherapy in pulmonary tuberculosis. Final report: results during the 36 months after the end of chemotherapy and beyond. British Thoracic Society.
    Br J Dis Chest; 1984 Oct; 78(4):330-6. PubMed ID: 6386028
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Six-month short course chemotherapy containing pyrazinamide for initial treatment of pulmonary tuberculosis].
    Wada M; Yosiyama T; Yosikawa M; Ogata H; Sugie T; Nakasono T; Sugita H
    Kekkaku; 1994 Nov; 69(11):671-80. PubMed ID: 7837720
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The short-term and long-term treatment outcomes in patients with pulmonary tuberculosis positive for drug-resistant and sensitive strains].
    Han JP; Sun SL; Li RZ; Zhang FS; Wang SC; Cheng J; Deng YF; Wang Y; Yu CB
    Zhonghua Jie He He Hu Xi Za Zhi; 2003 Feb; 26(2):70-3. PubMed ID: 12783654
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Results of a therapeutic trial comparing a 6-month regimen to a 12-month regimen in the treatment of pulmonary tuberculosis in the Algerian Sahara. Final report: results 3 years after the onset of treatment].
    Berkani M; Chaulet P; Darbyshire JH; Nunn A; Fox W
    Rev Mal Respir; 1986; 3(2):73-85. PubMed ID: 3726263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Agranulocytosis due to anti-tuberculosis drugs including isoniazid (INH) and rifampicin (RFP)--a report of four cases and review of the literature].
    Shishido Y; Nagayama N; Masuda K; Baba M; Tamura A; Nagai H; Akagawa S; Kawabe Y; Machida K; Kurashima A; Komatsu H; Yotsumoto H
    Kekkaku; 2003 Nov; 78(11):683-9. PubMed ID: 14672045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Survey of the initial treatment of pulmonary tuberculosis in West Germany. A study by the German Central Committee for the Prevention of Tuberculosis].
    Zierski M; Hoffmann O; Bornhardt E
    Pneumologie; 1989 Dec; 43(12):691-702. PubMed ID: 2622876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pulmonary tuberculosis. 2. Therapy].
    Bölcskei P
    Fortschr Med; 1983 Jun; 101(23):1075-80, 1090. PubMed ID: 6411560
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of two short course tuberculosis chemotherapy regimens, both using Rifater during an intensive phase, with a 3 year follow-up.
    Punnotok J; Pumprueg U; Chakorn T
    J Med Assoc Thai; 1995 Jun; 78(6):298-304. PubMed ID: 7561554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of kanamycin, ethionamide, PAS and cycloserine in multidrug-resistant pulmonary tuberculosis patients.
    Prasad R; Verma SK; Sahai S; Kumar S; Jain A
    Indian J Chest Dis Allied Sci; 2006; 48(3):183-6. PubMed ID: 18610675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effectivity of intermittent RMP/EMB treatment in patients with chronic pulmonary tuberculosis (author's transl)].
    Frenzel I; Neumeyer D
    Z Erkr Atmungsorgane; 1976 Aug; 146(2):145-52. PubMed ID: 1020361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Nine month chemotherapy with INH and rifampicin for non-cavitary pulmonary tuberculosis].
    Kino C; Sato M; Iwasaki T; Takase A; Kinoshita T; Yamaguchi T; Kinjo T; Odo A; Hara M; Hirata H
    Kekkaku; 1991 Apr; 66(4):291-7. PubMed ID: 2051705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.